Compare BANR & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BANR | PLSE |
|---|---|---|
| Founded | 1890 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.8B |
| IPO Year | 2015 | 2015 |
| Metric | BANR | PLSE |
|---|---|---|
| Price | $65.68 | $25.73 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $70.00 | $22.00 |
| AVG Volume (30 Days) | 206.7K | ★ 279.7K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.14% | N/A |
| EPS Growth | ★ 15.57 | N/A |
| EPS | ★ 1.60 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.73 | $840.00 |
| Revenue Next Year | $5.69 | $287.54 |
| P/E Ratio | $40.52 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $57.05 | $12.56 |
| 52 Week High | $69.83 | $28.53 |
| Indicator | BANR | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 52.94 | 54.43 |
| Support Level | $62.40 | $23.94 |
| Resistance Level | $67.78 | $27.82 |
| Average True Range (ATR) | 1.38 | 1.83 |
| MACD | -0.02 | -0.11 |
| Stochastic Oscillator | 63.21 | 46.25 |
Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho, and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.